John V. Oyler Salary and Compensation - BeOne Medicines Ltd. CEO Pay 2025

In fiscal year 2025, John V. Oyler, Co-Founder, Chairman and Chief Executive Officer of BeOne Medicines Ltd. (ONC), received total compensation of $5.6 million.

John V. Oyler's compensation breakdown includes: stock awards valued at $3.7 million, option awards of $3.7 million, non-equity incentive compensation of $1.7 million, and other compensation of $134K.

Compared to fiscal year 2024, John V. Oyler's total compensation decreased 73% from $20.8 million to $5.6 million.

BeOne Medicines Ltd. (ONC) Executive Pay 2025

BeOne Medicines Ltd.'s top 5 named executive officers received combined total compensation of $15.1 million in fiscal year 2025.

The named executive officers disclosed in BeOne Medicines Ltd.'s 2025 proxy statement are:John V. Oyler (Co-Founder, Chairman and Chief Executive Officer) with total compensation of $5.6 million, Xiaobin Wu (President, Chief Operating Officer and General Manager of China) with total compensation of $3.7 million, Lai Wang (Global Head of Research and Development) with total compensation of $2.4 million, Aaron Rosenberg (Chief Financial Officer) with total compensation of $1.9 million, and Chan Lee (Senior) with total compensation of $1.6 million.